Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Indices offer a practical way to quantify risk exposure and monitor changes over time, supporting proactive adjustments.
26,885 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A prominent real estate fund made a bold $5 million move on InvenTrust Properties as the stock trailed the S&P 500. T...
Struggling to get a handle on debt and a budget that actually sticks? This expert guide exposes the most common debt ...
Sandisk has delivered an extraordinary rally, but can it keep climbing? This guide breaks down what powered the move,...
A rough week for stocks left many investors wonder what comes next. This guide breaks down why the Dow tumbled and th...
Hyperliquid and Cardano sit near the same market cap, but they serve very different purposes in crypto. This guide br...
A new Samsung-deepseek partnership is stirring the AI hardware scene. This guide breaks down what DeepSeek could mean...
A major share sale by Orbimed Advisors in Enliven Therapeutics coincides with a sharp stock rally. This guide breaks ...
Walmart and Costco sit at opposite ends of the discount retail universe, yet both deserve a spot on a thoughtful inve...
CubeSmart sits in a crowded self-storage field. This guide breaks down the key indicators I watch to assess whether C...
Chip stocks are back in the spotlight as AI and data demand push hardware needs higher. This article weighs Micron ag...
As SpaceX prepares to enter the public markets, investors face a mix of hype and risk. This guide unpacks what histor...